Found: 10
Select item for more details and to access through your institution.
Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 21, p. 2819, doi. 10.1001/jama.289.21.2819
- By:
- Publication type:
- Article
Recruitment of a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 11, p. 1808, doi. 10.1002/alz.12401
- By:
- Publication type:
- Article
Recruitment for a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial: Prevention (nonpharmacological) / Exercise.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044658
- By:
- Publication type:
- Article
Specialty clinics for adults with Down syndrome: A clinic survey.
- Published in:
- American Journal of Medical Genetics. Part A, 2021, v. 185, n. 6, p. 1767, doi. 10.1002/ajmg.a.62169
- By:
- Publication type:
- Article
Revising the administration of the ADAS-Cog.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P857, doi. 10.1016/j.jalz.2014.05.1704
- By:
- Publication type:
- Article
Performance on ADAS-Cog items across ADCS trials
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Extent and impact of missing ADAS-cog items in ADCS clinical trials
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Errors in adas-cog administration and scoring may undermine clinical trials results
- Published in:
- 2010
- By:
- Publication type:
- Abstract
A phase I study of AIT-082 in healthy elderly volunteers.
- Published in:
- Journal of Molecular Neuroscience, 2002, v. 18, n. 3, p. 283, doi. 10.1385/JMN:18:3:283
- By:
- Publication type:
- Article
Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00938-w
- By:
- Publication type:
- Article